🇺🇸 FDA
Patent

US 11331323

Pharmaceutical compositions comprising meloxicam

granted A61KA61K31/4196A61K31/5415

Quick answer

US patent 11331323 (Pharmaceutical compositions comprising meloxicam) held by AXSOME THERAPEUTICS, INC. expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4196, A61K31/5415, A61K47/6951, A61K9/2013